Remarkably, all AD-selective DEGs in the brain were addressed in the CBD-treated 3xTg-AD group with the exception of the ubiquitin gene Usp18 (Widjaya et al., 2023; Xiang et al., 2018). This evidence concerns the gene UBC and Alzheimer disease.